Today’s Solutions: May 12, 2025

According to the CDC, there are around 30,000 Lyme disease infections reported in the US every year. This number is likely to be much higher, with estimations of actual infections being eight to 10 times more than those recorded. The little critters responsible for the disease are blacklegged ticks (Ixodes scapularis), which transmit the bacterium Borrelia burgdorferi into the host causing the infection. Symptoms include fatigue, headaches, fever, and in more severe untreated cases, the infection can spread around the body causing paralysis and death.

How does the vaccine work?

Ticks are expanding into new territories across the midwest, meaning cases of Lyme disease are also expected to grow. To confront this issue, a team from the Yale School of Medicine has created a vaccine. The way it works is by stopping the ticks from being able to feed and multiply within the host’s skin, in this way stopping the bacteria from entering. The team utilized a type of RNA in the vaccine, which works by carrying instructions on how to fight off the invasion.

So who were the guinea pigs that were involved in the novel vaccine trial? It turns out it was actual guinea pigs, with results showing “robust immunity” against Lyme disease in these creatures. The study, published in Science Translational Medicine, found that two weeks after receiving the injection, a substantial immune reaction was achieved. The response works by creating inflammation around the area of the bite, causing the ticks to dislodge. Alongside this, protective proteins in the blood are recruited to fight against bacterial infection.

A major step towards a vaccine against Lyme disease

“The authors demonstrated that early tick removal, together with the [vaccine]-driven inflammatory reaction around the tick bite, is a key step toward the development of a vaccine for preventing Lyme disease transmission,” said the research group in a statement published in Science Translational Medicine. Although humans are considerably different from guinea pigs, more testing and clinical trials need to occur in the future to see if this immunity would transfer in the same manner.

Source study: Science Translational Medicine – mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent

Solutions News Source Print this article
More of Today's Solutions

Scientists use living human brain tissue to model Alzheimer’s to accelerate s...

BY THE OPTIMIST DAILY EDITORIAL TEAM In a world-first, British scientists replicated the early stages of Alzheimer’s disease using living human brain tissue — ...

Read More

How to spot a good boss: 3 science-backed tips to guide your next career move

BY THE OPTIMIST DAILY EDITORIAL TEAM If you’ve ever had a bad boss, you’re not alone. Studies show that up to 65 percent of ...

Read More

This ingenious solution tackles food waste and insecurity at once

Food waste is a particularly infuriating problem because so much is wasted. According to nonprofit FoodPrint, almost 40 percent of all food in America, ...

Read More

Beating the heat: Your comprehensive guide to staying cool and safe in extrem...

BY THE OPTIMIST DAILY EDITORIAL TEAM In light of the extreme coast-to-coast heat hitting the United States and Canada, this week we're bringing back ...

Read More